The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
Ben J. Van den Branden*, MD; Justin G. Luermans, MD, PhD; Martijn C. Post, MD, PhD; Herbert W. Plokker, MD, PhD; Jurriën M. ten Berg, MD, PhD; Maarten J. Suttorp, MD, PhD
Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
Aims: To compare the mid-term efficacy and safety of the bioabsorbable BioSTAR® device with the non-bioabsorbable CardioSEAL® dev
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
transcatheter closurepatent foramen ovaleresidual shunt
Read next article
The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach